周四盘中，威高股份（01066）股价大涨5.49%，投资者反应积极。这波涨势很可能与其子公司威高骨科（688161.SH）最新发布的2024年度业绩报告密切相关。
根据公告，威高骨科2024年度实现营收14.53亿元人民币，同比增长13.18%；更引人注目的是，归属于上市公司股东的净利润达2.24亿元，同比劲增99.22%。每股基本收益为0.56元。此外，公司还提议向全体股东每10股派发1.70元人民币（含税）的现金红利，进一步提振了投资者信心。
威高骨科在报告中指出，尽管面临骨科耗材带量采购的挑战，公司通过积极调整经营策略，全面提升了市场份额和客户覆盖率。同时，公司加强了精细化绩效管理，优化了营销架构和库存管理，提高了供应链效率，有效降低了销售费用率。这些措施共同促成了本报告期内的显著业绩增长，也为威高股份的股价上涨提供了有力支撑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.